Evidence map›Paper›PMID 27431371›Full record

ReviewAnnual review of nutrition2016

Lutein and Zeaxanthin Isomers in Eye Health and Disease.

Julie Mares

Open access · bronzeAbstract readReview
In one paragraph

Review in Annual review of nutrition, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed, 2 pooled it
8.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 2 syntheses or guidelines pooled it, 246 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. BlingLifeJournal of microbiology and biotechnology · 2025
    Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Julie MaresDepartment of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, Wisconsin 53726-2336; email: Jmarespe@wisc.edu.
University of Wisconsin–Madison · US

Funding

Macular Pigment in Aging and DiseaseR01EY025292 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI BLODI, BARBARA A, MARES, JULIE A · 2015 to 2019
$4.5M
CAROTENOIDS &AGE-RELATED EYE DISEASE IN WOMEN'S HEALTHU10EY013018 · NEI · UNIVERSITY OF WISCONSIN MADISON · PI MARES, JULIE A · 2000 to 2004
$4.4M
Diet and Lifestyle Factors Reducing Risk for Age-Related Eye DiseaseR01EY016886 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI IYENGAR, SUDHA K, MARES, JULIE A · 2007 to 2013
$2.7M
NEI NIH HHS R01 EY016886NEI NIH HHS R01 EY025292NEI NIH HHS U10 EY013018
6 · The paper itself

Abstract

Current evidence suggests lutein and its isomers play important roles in ocular development in utero and throughout the life span, in vision performance in young and later adulthood, and in lowering risk for the development of common age-related eye diseases in older age. These xanthophyll (oxygen-containing) carotenoids are found in a wide variety of vegetables and fruits, and they are present in especially high concentrations in leafy green vegetables. Additionally, egg yolks and human milk appear to be bioavailable sources. The prevalence of lutein, zeaxanthin, and meso-zeaxanthin in supplements is increasing. Setting optimal and safe ranges of intake requires additional research, particularly in pregnant and lactating women. Accumulating evidence about variable interindividual response to dietary intake of these carotenoids, based on genetic or metabolic influences, suggests that there may be subgroups that benefit from higher levels of intake and/or alternate strategies to improve lutein and zeaxanthin status.

Indexed as

Dietary SupplementsDiet, HealthyModels, BiologicalAge FactorsAnimalsAnti-Inflammatory Agents, Non-SteroidalAntioxidantsEye DiseasesHumansLuteinOrgan SpecificityOxidative StressRetinaStereoisomerismVision DisordersZeaxanthinsAnti-Inflammatory Agents, Non-SteroidalAntioxidantsLuteinZeaxanthinscarotenoidscataractmaculamacular degenerationretinopathyvision

Identifiers

PMID27431371
PMCPMC5611842
OpenAlexW2489455328

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.